arginine has been researched along with bosentan anhydrous in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Clozel, M; Hogie, M; Löffler, BM; Richard, V; Thuillez, C | 2 |
| Clozel, JP; Clozel, M; Hess, P; Véniant, M | 1 |
| Baylis, C; Engels, K; Qiu, C | 1 |
| Deng, LY; Deschepper, CF; Grove, K; Li, JS; Schiffrin, EL | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
| Bauer, M; Clemens, MG; Pannen, BH; Robotham, JL; Zhang, JX | 1 |
| Keiser, HR; Oriji, GK | 1 |
| Bartholomeusz, B; Hardy, KJ; Nelson, AS; Phillips, PA | 1 |
| Fischer, SR; Traber, DL | 1 |
| Breu, V; Löffler, BM; Scommotau, S; Spiegel, HU; Uhlmann, D | 1 |
| Erzurum, SC; Lara, AR | 1 |
| Howard, LS; Morrell, NW | 1 |
| Bergstrom, KG; Perelman, RO | 1 |
| Adams, MR; Celermajer, DS; Ilsar, R; Kritharides, L; Levitt, J; Ng, MK | 1 |
2 review(s) available for arginine and bosentan anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New therapeutic agents for pulmonary vascular disease.
Topics: Adult; Antihypertensive Agents; Arginine; Bosentan; Child; Drug Therapy, Combination; Epoprostenol; Humans; Hypertension, Pulmonary; Iloprost; Nitric Oxide; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Sulfonamides | 2005 |
17 other study(ies) available for arginine and bosentan anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats.
Topics: Animals; Arginine; Blood Pressure; Bosentan; Endothelins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Peptides, Cyclic; Phenylephrine; Rats; Rats, Wistar; Sulfonamides | 1995 |
Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs.
Topics: Animals; Arginine; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Guinea Pigs; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Peptides, Cyclic; Sulfonamides | 1994 |
[Demonstration of a vasopressor role of endogenous endothelin after inhibition of nitric oxide synthesis in rats].
Topics: Animals; Arginine; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Endothelins; Male; Nitric Oxide; Nitroarginine; Peptides, Cyclic; Phenylephrine; Rats; Rats, Wistar; Sulfonamides; Vasoconstriction | 1995 |
Endothelin modulates the pressor actions of acute systemic nitric oxide blockade.
Topics: Animals; Arginine; Bosentan; Endothelins; Enzyme Inhibitors; Glycopeptides; Hemodynamics; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstriction | 1995 |
Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascu
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Bosentan; Cilazapril; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Gene Expression; Hypertension; In Situ Hybridization; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Inbred SHR; Receptors, Endothelin; Renin; Sulfonamides; Vascular Resistance | 1996 |
Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats.
Topics: Animals; Arginine; Bosentan; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sulfonamides | 1996 |
A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin.
Topics: Animals; Arginine; Blood Pressure; Bosentan; Endothelins; Endotoxins; Enzyme Inhibitors; Hemodynamics; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Portal System; Portal Vein; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Time Factors; Vascular Resistance | 1996 |
Role of nitric oxide in cyclosporine A-induced hypertension.
Topics: Animals; Aorta; Arginine; Blood Pressure; Bosentan; Cyclic GMP; Cyclosporine; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; Immunosuppressive Agents; Male; Nitrates; Nitrites; Olive Oil; Penicillamine; Peptides, Cyclic; Plant Oils; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstriction | 1998 |
Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Pressure; Bosentan; Callithrix; Cyclosporine; Enzyme Inhibitors; Female; Hypertension; Immunosuppressive Agents; Male; Nitrates; Nitric Oxide; Nitrites; Nitroarginine; Rats; Rats, Wistar; Sulfonamides; Systole | 1998 |
L-arginine and endothelin receptor antagonist bosentan counteract hemodynamic effects of modified hemoglobin.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Substitutes; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Hemoglobins; Nitric Oxide; Polyethylene Glycols; Sepsis; Sheep; Sulfonamides; Vasoconstriction | 1999 |
Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury.
Topics: Alanine Transaminase; Animals; Arginine; Aspartate Aminotransferases; Bosentan; Endothelin Receptor Antagonists; Endothelins; Female; L-Lactate Dehydrogenase; Liver; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides | 1999 |
A urinary test for pulmonary arterial hypertension?
Topics: Antihypertensive Agents; Arginine; Bosentan; Humans; Hypertension, Pulmonary; Nitric Oxide; Pulmonary Artery; Sulfonamides | 2005 |
Treatment for Raynaud's: beyond calcium channel blockers.
Topics: Arginine; Bosentan; Botulinum Toxins; Calcium Channel Blockers; Humans; Piperazines; Prazosin; Purines; Raynaud Disease; Sildenafil Citrate; Sulfonamides; Sulfones | 2008 |
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension.
Topics: Acetylcholine; Aged; Antihypertensive Agents; Arginine; Bosentan; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Pulmonary Artery; Sulfonamides; Ultrasonography | 2010 |